← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Pacific Health Research/ Education Inst
Honolulu, HI
$10,871,680
Total funding
9
Grants
Funding over time
peak $3.2M · FY2008–23$5M$3.8M$2.5M$1.3M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$10,871,680 · 9
By mechanism
RF1$3,364,645 · 1
UF1$2,640,684 · 1
N01$2,500,271 · 1
R01$1,553,096 · 3
R21$391,293 · 1
U10$271,822 · 1
Investigators at Pacific Health Research/ Education Inst
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Apolipoprotein E2 and Brain Aging$3,109,699
RF1 · FY2017 · AG
Cognitive resilience to Alzheimer neuropathologic changes in the Honolulu-Asia Aging Study and the Nun Study$2,640,684
UF1 · FY2016 · AG
Prostate, Lung, Colorectal and Ovarian (PLCO) Screening Trial$1,250,136
N01 · FY2010 · CA
National Lung Study Trial$1,250,135
N01 · FY2010 · CA
Evaluation of Multivariate Causal Factors Linking the Flynn Effect to Declining Dementia Trends and Cognitive Aging$706,393
R01 · FY2023 · AG
Reducing Cost-Related Medication Nonadherence in Persons with Diabetes$521,725
R01 · FY2010 · DK
Apolipoprotein E2 and Brain Aging$254,946
RF1 · FY2018 · AG
Reducing Cost-Related Medication Nonadherence in Persons with Diabetes$250,639
R01 · FY2011 · DK
Genetics of Telomere Dynamics in Okinawans$216,750
R21 · FY2014 · AG
Genetics of Telomere Dynamics in Okinawans$174,543
R21 · FY2013 · AG
Diabetes and Obesity: Associations with Cognition, Neuropathology, and Longevity$82,234
R03 · FY2014 · AG
Diabetes and Obesity: Associations with Cognition, Neuropathology, and Longevity$67,635
R03 · FY2015 · AG
Continuation of NET-PD Trials at the Hawaii Center$66,830
U10 · FY2013 · NS
Parkinson's Disease Neuroprotection Trial: Hawaii Center$61,376
U10 · FY2012 · NS
Parkinson's Disease Neuroprotection Trial: Hawaii Center$58,047
U10 · FY2011 · NS
Risk Factors for Pathologic Markers of Parkinson Disease$56,496
R01 · FY2010 · NS
Parkinson's Disease Neuroprotection Trial: Hawaii Center$42,969
U10 · FY2010 · NS
Parkinson's Disease Neuroprotection Trial: Hawaii Center$42,600
U10 · FY2010 · NS
Risk Factors for Pathologic Markers of Parkinson Disease$17,843
R01 · FY2008 · NS